Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
US8680050B2 · kind B2 · utility
25Cited by
14References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2010 |
| Grant date | Mar 25, 2014 |
| Priority date | — |
| Expiry date | Aug 2, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/75
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to compositions comprising growth hormone linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in administration to animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.